1. Home
  2. SPT vs FLGT Comparison

SPT vs FLGT Comparison

Compare SPT & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPT

Sprout Social Inc

HOLD

Current Price

$12.69

Market Cap

485.7M

Sector

Technology

ML Signal

HOLD

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$20.11

Market Cap

511.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPT
FLGT
Founded
2010
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
485.7M
511.0M
IPO Year
2019
2016

Fundamental Metrics

Financial Performance
Metric
SPT
FLGT
Price
$12.69
$20.11
Analyst Decision
Hold
Analyst Count
10
0
Target Price
★ $10.67
N/A
AVG Volume (30 Days)
★ 714.3K
242.4K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 32.11
N/A
EPS
N/A
★ N/A
Revenue
★ $457,547,000.00
$18,730,000.00
Revenue This Year
$8.10
$2.80
Revenue Next Year
$6.01
$15.38
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 12.72
N/A
52 Week Low
$4.92
$13.46
52 Week High
$12.73
$31.04

Technical Indicators

Market Signals
Indicator
SPT
FLGT
Relative Strength Index (RSI) 71.60 43.15
Support Level $9.08 $19.35
Resistance Level N/A $21.56
Average True Range (ATR) 0.51 0.92
MACD 0.21 -0.21
Stochastic Oscillator 94.39 11.15

Price Performance

Historical Comparison
SPT
FLGT

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

Share on Social Networks: